ePT--the Electronic Newsletter of Pharmaceutical Technology
Arthur R. Mlodozeniec, PhD, a member of Pharmaceutical Technology's advisory board and past president of AAPS, died on Sept. 4.
Arthur R. Mlodozeniec, PhD., a noted lecturer and consultant and member of Pharmaceutical Technology’s Editorial Advisory Board, died on Sept. 4 at his home in Menlo Park, CA. He was 69 years old.
His death was announced by his son-in-law, James McCormick.
Dr. Mlodozeniec was a prominent contributor and advisor to Pharmaceutical Technology. His most recent article, “Challenging ‘The Process is the Product’: Clarifying the Role of Information Technology in Biopharmaceutical Process Development” appeared in the journal’s November 2004 supplement, Innovations in Information Technology.
At the time of his death, Dr. Mlodozeniec was lecturing on pharmaceutical technology at the University of California’s Berkeley and Santa Cruz campuses. He was also a consultant, working with such companies as Baxter, Eli Lilly, and Genentech, and he served as past president of the American Association of Pharmaceutical Scientists (AAPS) and chair of AAPS’s Generic Focus Group. He was a Fellow of AAPS, the American Pharmaceutical Association, and the American Association for the Advancement of Science.
Earlier in his career, he held positions as research scientist and section leader at Upjohn, group leader in advanced technology and director of quality control at Hoffmann-LaRoche, executive director and distinguished scientist at Merck, director of manufacturing engineering and pharmaceutical automation at Syntex, and chief scientific officer at PharmQuest Corp.
Dr. Mlodozeniec earned his bachelor’s degree in pharmacy from Fordham University and a PhD. in physical chemistry from the University of Wisconsin.
He is survived by his daughters, Tracey McCormick and Wendy Huigens; granddaughter Madison Huigens; brothers Gary and Eugene, and a sister, Joanne Young.
There will be a memorial service on Saturday, Sept. 23 at St. Bernard’s, 1990 Clinton St., in Buffalo, NY, where Dr. Mlodozeniec was born. Interment will follow at St. Stanislaus Cemetery. In lieu of flowers, the family asks that contributions be sent to the Arthur Mlodozeniec Pharmaceutical Scholarship Fund, The Bank of America, Account No. 11307-41783, 2180 Sand Hill Rd., Menlo Park, CA 94025.
Pharmaceutical Technology mourns his passing.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.